0

Global Gastrointestinal Therapeutics Market 2016-2020

  • Published: Sep 2016
  • Pages: 102
  • SKU: IRTNTR10476
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

This market research report analyzes the key players in the global gastrointestinal therapeutics market such as AbbVie, Allergan, Johnson & Johnson, Takeda, and UCB. The report also presents a competitive analysis of the market by disease type (IBD and IBS) and by geography (the Americas, APAC, and EMEA). 

Global gastrointestinal therapeutics market analysis

Technavio’s market research analysts predict the global gastrointestinal therapeutics market to grow steadily during the forecast period and will post a CAGR of more than 6% by 2020. This industry research report identifies the increasing consumption of biologics for inflammatory bowel diseases (IBD) to be one of the major factors that will have a positive impact on the growth of the gastrointestinal therapeutics market size in the coming years. Biologics that are available as intravenous or subcutaneous injections are the most preferred choices for the treatment of gastrointestinal diseases such as IBD. These therapeutics act by either blocking the interleukins or the TNF-α. HUMIRA, Remicade, and Cimzia, which are some anti-TNF agents whereas, Tysabri and ENTYVI are some of the anti-integrin agents available in the market for the treatment of conditions such as ulcerative colitis and Crohn's disease. In addition, several pharmaceutical companies are constantly making investments to develop advanced biologics for the treatment of IBD, which will further aid in the growth of the market over the predicted period.

The emergence of biosimilars will be one of the major trends that will gain traction in this market in the next four years. The increased usage of biologics will induce several countries across the globe to provide effective solutions for the treatment of inflammatory disorders, without increasing healthcare expenditure. This will lead to a rise in the adoption of biosimilars as they contain active pharmaceutical ingredients that are identical to their originator biologic compounds and are also less expensive than biologics.

Competitive landscape and key vendors

Though characterized by the presence of several large- and small-scale vendors, the market is dominated by a few major players such as AbbVie, Allergan, Johnson & Johnson, Takeda, and UCB. Johnson & Johnson accounts for a major share of the gastrointestinal therapeutics market with its drugs such as Remicade and Simponi. Though the sale of these drugs is set to mature during the forecast period, the company will retain its market position with its drug Simponi, which is expected to gain sales by 2020. Another major vendor AbbVie, that is set to retain its market presence with drugs like ABT-494 that is currently in trial for the treatment of Crohn’s disease, poses a tough competition to Johnson & Johnson with its drug Humira.

The leading vendors in the market are 

  • AbbVie
  • Allergan
  • Johnson & Johnson
  • Takeda
  • UCB

The other prominent vendors in the market are 4SC, Ajinomoto Pharmaceuticals, Alfa Wassermann, Alizyme, Amgen, Anterogen, Ardelyx, Arena Pharmaceuticals, Astellas, AstraZeneca, Astellas Pharma, Avaxia Biologics, Biogen Idec, BioLineRx, Celgene, ChemoCentryx, Drais Pharmaceuticals, Eisai, Eli Lilly, Enlivex Therapeutics, F. Hoffmann-La Roche, Ferring Pharmaceuticals, FF Pharma, Galapagos, Gilead Sciences, GlaxoSmithKline, Hutchison Medi Pharma, Immune Pharmaceuticals, InDex Pharmaceuticals, Ironwood Pharmaceuticals, Kaken Pharmaceutical, Kang Stem Biotech, Kissei Pharmaceutical, Kyowa Hakko Kirin, Lexicon Pharmaceuticals, Lipid Therapeutics, Meda, Merck, Mesoblast, Mitsubishi Tanabe, Mochida Pharmaceutical, Morphotek, Neovacs, Nestle, Norgine, Novartis, Ono Pharmaceutical, Pfizer, Procter & Gamble, Qu Biologics, Receptos, RedHill Biopharma, Salix Pharmaceuticals, Shield Therapeutics, Shire Pharmaceuticals, Sterna Biologicals, Synergy Pharmaceuticals, Synthetic Biologics, TiGenix, Tillotts Pharma, TopiVert, TSD Japan, and Zeria Pharmaceutical.

Segmentation by disease type and analysis of the gastrointestinal therapeutics market

Accounting for more than 88% of the total market shares, the IBD disease market segment dominated the market during 2015. IBD involves a group of autoimmune diseases such as Crohn's disease and ulcerative colitis and is expected to grow at a CAGR of more than 5% in the next four years.

Geographical segmentation and analysis of the gastrointestinal therapeutics market

  • Americas
  • APAC
  • EMEA

In terms of geographical regions, the Americas will account for almost 55% of the total market shares by 2020 and will also be the major revenue contributor to the gastrointestinal therapeutics market throughout the forecast period. The rising acceptance of biologics and the introduction of healthcare reforms by various countries in the region will augment the market’s growth prospects in the next four years.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2020?
  • What are the key factors driving the global gastrointestinal therapeutics market?
  • What are the key market trends impacting the growth of the global gastrointestinal therapeutics market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global gastrointestinal therapeutics market?
  • What are the market opportunities and threats faced by the vendors in the global gastrointestinal therapeutics market?
  • Trending factors influencing the market shares of the Americas, APAC, and EMEA.
  • What are the key outcomes of the five forces analysis of the global gastrointestinal therapeutics market?

Technavio also offers customization on reports based on specific client requirement.

Related reports

Table of Contents

PART 01:Executive summary

  • Highlights

PART 02:Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03:Market research methodology

  • Research methodology
  • Economic indicators

PART 04:Introduction

  • Key market highlights

PART 05:Pipeline portfolio

  • Ulcerative colitis
  • Crohn's disease
  • IBS

PART 06:Market landscape

  • Global gastrointestinal therapeutics market

PART 07:Market segmentation by disease type

  • Overview

PART 08:Global IBD therapeutics market

  • Global ulcerative colitis drugs market
  • Global Crohn's disease drugs market
  • Market segmentation by molecule type

PART 09:Global IBS therapeutics market

PART 10:Global gastrointestinal OTC drugs market

PART 11:Geographical segmentation

  • Global gastrointestinal therapeutics market by geography 2015-2020
  • Gastrointestinal therapeutics market in Americas
  • Gastrointestinal therapeutics market in EMEA
  • Gastrointestinal therapeutics market in APAC

PART 12:Market drivers

  • Increasing consumption of biologics
  • Tentative approval of late stage molecules
  • Development of novel therapies using innovative technologies
  • Improved diagnostic tools increasing the treatment-seeking population

PART 13:Impact of drivers

PART 14:Market challenges

  • Increased consumption of OTC medications
  • Unknown etiology of IBD and IBS
  • Discontinuation of drugs under development and from the market

PART 15:Impact of drivers and challenges

PART 16:Market trends

  • Patient assistance programs
  • Emergence of biosimilars
  • Rise in self-medication
  • Focus on regenerative medicines
  • Strategic alliances and M&A

PART 17:Vendor landscape

  • Competitive scenario
  • Other prominent vendors

PART 18:Key vendor analysis

  • AbbVie
  • Johnson & Johnson
  • Takeda
  • Allergan
  • UCB

PART 19:Appendix

  • List of abbreviations

PART 20:Explore Technavio

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO recognized

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted
Technavio

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Technavio
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>